Sign in

CIK 0001638097

  • Non-accelerated filer
  • Smaller reporting company

Entera Bio Ltd.

Sign in to watch
Ticker
ENTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 25327151
Business address
KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
  1. 3 Insider Initial Statement of Ownership
  2. 4 Grant or award Director acquired 7,278 shares (grant or award)
  3. 4 Grant or award Director acquired 8,452 shares (grant or award)
  4. 4 Grant or award Director acquired 8,639 shares (grant or award)
  5. 4 Grant or award Director acquired 11,269 shares (grant or award)
  6. 4 Grant or award Director acquired 7,466 shares (grant or award)
  7. 4 Grant or award Director acquired 20,446 shares (grant or award)
  8. 4 Grant or award Director acquired 15,335 shares (grant or award)
  9. 4 Grant or award Director acquired 18,061 shares (grant or award)
  10. 4 Grant or award Director acquired 23,172 shares (grant or award)
  11. 4 Grant or award Director acquired 27,261 shares (grant or award)
  12. 4/A Grant or award Chief Financial Officer acquired 30,151 shares (grant or award)
  13. 4 Grant or award Chief Executive Officer acquired 124,121 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award Chief Financial Officer acquired 30,151 shares (grant or award)
  16. 4 Grant or award Chief Operating Officer acquired 30,151 shares (grant or award)
  17. 4 Open-market buy Director bought 9,500 shares at $0.99 ($9,405)
  18. 4 Open-market buy Director bought 7,615 shares at $0.77 ($5,864)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 7 · 126 filings